BRIGHAM AND WOMEN'S HOSPITAL
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease is a funding opportunity from BRIGHAM AND WOMEN'S HOSPITAL, up to 1530450, closing May 31, 2031.
May 31, 2031
(1765d left)Overview
Summary/Abstract This Asthma and Allergic Disease Cooperative Research Center (AADCRC) grant continues to focus on the mechanistic basis of respiratory tract type 2 immunopathology (T2I), particularly in aspirin-exacerbated respiratory disease (AERD), a distinctive clinical syndrome that accounts for a…